Phibro Animal Health is focusing on new developments along with incremental registrations and growing volumes of existing ...

While the historical EPS growth rate for Phibro is 0.9%, investors should actually focus on the projected growth. The company's EPS is expected to grow 35.7% this year, crushing the industry average, ...

In today’s Daily Kickoff, we look at possible pathways forward for the Antisemitism Awareness Act in the new Congress and report on President–elect Donald Trump’s appointment of Morgan Ortagus as ...

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday morning. Other analysts ...

Phibro Animal Health PAHC has seen impressive momentum in the past year, with its shares soaring 82.8%. It has significantly outperformed the 9.6% rise of the industry and the S&P 500 Composite’s 26.7 ...